ESRD (End Stage Renal Disease) refers to permanent kidney failure. It is the final stage of Chronic Kidney Disease (CKD) where the kidney functions at less than 10-15% of the normal capacity. The growing prevalence of diabetes, hypertension and large elderly population are rapidly driving the number of ESRD patients globally. There are two methods used for treating ESRD patients: kidney transplant or dialysis. Dialysis is the process of blood purification i.e. the removal of waste and toxic substances from the body and it can be done via two procedures viz. peritoneal dialysis (PD) or hemodialysis (HD). The major dialysis products include dialyzers, hemodialysis machines, dialysis concentrates and peritoneal dialysis products. Diabetes and high blood pressure are among the key causative factors for kidney failure leading to an increase in the number of patients suffering from CKD and ESRD. This report analyzes the global dialysis market with focus on its segments including: dialysis services, dialysis products, and dialysis drugs. Moreover the regional market of China is also discussed. Furthermore market dynamics such as the industry trends and development, key growth drivers and challenges faced by the industry are also elicited in detail. On the contention front, the global dialysis market is fiercely competitive with a handful of player reining the whole market. The key industry players are Baxter, Fresenius, DaVita and Gambro. The competitive landscape of the industry along with the key industry players’ profiles are also added herein.

1. Global Dialysis Market Report
---------------------------------------------------
2013
View Report Details

2. Executive Summary
ESRD (End Stage Renal Disease) refers to permanent kidney failure. It is the final stage of Chronic Kidney Disease (CKD) where
the kidney functions at less than 10-15% of the normal capacity. The growing prevalence of diabetes, hypertension and large
elderly population are rapidly driving the number of ESRD patients globally. There are two methods used for treating ESRD
patients: kidney transplant or dialysis.
Dialysis is the process of blood purification i.e. the removal of waste and toxic substances from the body and it can be done via
two procedures viz. peritoneal dialysis (PD) or hemodialysis (HD). The major dialysis products include dialyzers, hemodialysis
machines, dialysis concentrates and peritoneal dialysis products. Diabetes and high blood pressure are among the key causative
factors for kidney failure leading to an increase in the number of patients suffering from CKD and ESRD.
This report analyzes the global dialysis market with focus on its segments including: dialysis services, dialysis products, and
dialysis drugs. Moreover the regional market of China is also discussed. Furthermore market dynamics such as the industry trends
and development, key growth drivers and challenges faced by the industry are also elicited in detail. On the contention front, the
global dialysis market is fiercely competitive with a handful of player reining the whole market. The key industry players are Baxter,
Fresenius, DaVita and Gambro. The competitive landscape of the industry along with the key industry players’ profiles are also
added herein.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth
of the industry. We employed various significant variables that have an impact on this industry and created regression models with
SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between
several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including
charts, tables and tests.
View Report Details

3. End Stage Renal Disease or ESRD is the final stage of CKD and the patients require dialysis i.e. artificial
filtering of blood or a kidney transplant …….
In 2012, the global dialysis market was estimated to be worth US$.....
billion growing on the back of rapidly rising number of ESRD patients.
The respective market grew at an impressive CAGR of …..% over the
six year period spanning from 2006 to 2012. In y-o-y terms, as
compared to 2011 revenues, the global dialysis market recorded a
modest increase of approximately ..%, reaching US$... billion in 2012.
As of 2012, …% of the total patients suffering from ESRD underwent
hemodialysis and …..% chose to go for peritoneal dialysis. Almost,
…..% of the patients had to undergo surgical procedure for kidney
transplant.
The global dialysis market can be divided into segments viz.: Dialysis
Services, Dialysis Drugs and Dialysis Products. The dialysis services
segment held a sky rocketing share of ……% while the dialysis products
claimed a modest share of …..% in the year 2012.
Global Dialysis Market (2006-2012)
2009 2010 2011 2012
%
Hemodialysis Peritoneal Dialysis Transplants
Global Share of ESRD Treatment Procedures (2009-2012)
Global Dialysis Market Share by Segments (2012)
2006 2007 2008 2009 2010 2011 2012
US$Billion
Dialysis Services Dialysis Products Dialysis Drugs

4. Dialysis patients can be treated either at their own homes or at dialysis centers..…
 Globally, the dialysis products market was worth US$...billion in
2007, registering a consistent growth thereafter, reaching US$
….billion in 2012. Over the cited period the global dialysis
products market grew at a CAGR of …%. In y-o-y terms, the
respective market registered an increase of US$....billion.
 The dialysis services segment, including the drugs, stood at
US$.....billion in 2007, which increased to US$....billion in 2012,
thereby witnessing a stagnant growth from the previous year
2011.
 In 2012, being the most popular choice of treatment, center
dialysis had the maximum share i.e. ….% on the global scale,
while home dialysis held a modest share of …..%.
Global Dialysis Services Market (2007-2012)
Global Dialysis Product Market (2007-2012)
2007 2008 2009 2010 2011 2012
US$Billion
Worldwide Breakdown of Center Dialysis & Home Dialysis (2012)
2007 2008 2009 2010 2011 2012
US$Billion
Centre Dialysis Home Dialysis

5. In the present era of changing lifestyle, diabetes is the fastest growing disease worldwide; one of the
major causes of kidney failure or ESRD….…
As of 2012, the International Diabetes Foundation claimed that of
the number of diabetic people all over the world has reached
…….million in comparison with ………million in 2011. IDF also
estimated that this population is likely to reach …....million by 2030.
In terms of revenue, the three largest manufacturers of dialysis
products together accounted for approximately …..…% of the
worldwide market in 2012. With a market share of almost …..…%,
FMC led the segment followed by Baxter and Gambro.
Asia Pacific is the key region contributing to the total number of
dialysis patients, accounting for almost ……% of the global dialysis
patient population in 2012. The other key geographic zone is EMEA
which claimed around ………% share of the global dialysis patient
population over the period cited.
Global Dialysis Products Market Share (2012)
Global Diabetes Population (2006-2012)
2006 2007 2008 2009 2010 2011 2012
US$Billion
Dialysis Patient Population Share by Region (2012)
FMC Baxter Gambro Others
Asia Pacific EMEA North America Latin America

6. The dialysis market is bifurcated into two key product segments viz. Hemodialysis and Peritoneal
Dialysis….……
• The hemodialysis segment was led by FMC with a substantial share of 37%, followed by Gambro accounting for 16% of the
same during 2012 while Baxter constituted for a modest share of 3% in the hemodialysis product segment.
• In the area of peritoneal dialysis, Baxter reined the market by accounting for the highest market share of 72% while FMC
claimed a 20% share of global market in revenue terms. Particularly in the US, FMC held 42% of the market share by
positioning itself firmly in home dialysis market, which comprises of home hemodialysis and peritoneal dialysis products.
• China is an emerging market, after US, in dialysis segment. The government is making efforts to develop a modern
healthcare system for opening the dialysis market for international providers.
• For 2013, the global dialysis market revenues are estimated to reach US$........ billion, likely to register a y-o-y growth of
…………% as compared to the market value of US$..........billion recorded in 2012. The market is projected to grow at a
CAGR of ………% over the 3 year period spanning from 2012 to 2015, and is poised to reach US$.......... billion by the end
of 2015. The estimated growth is likely to occur due to the steady rise in the number of patients suffering from kidney
diseases, particularly ESRD.
Hemodialysis Products Market Share (2012)
FMC Gambro Baxter Others
Peritoneal Dialysis Products Market Share (2012)
Baxter FMC Others

7. Table of Contents
1. Overview
1.1 Chronic Kidney Disease (CKD)
1.2 End Stage Renal Disease (ESRD)
1.2.1 Treatments for ESRD
2. Market Size
2.1 Global Dialysis Market
-Market Value
-Dialysis Services Market
-Dialysis Products Market
2.2 China’s Dialysis Market
-Market Overview
-Manufacturers by Region
3. Market Dynamics
3.1 Key Trends and Developments
3.1.1 Distribution of Dialysis Clinics
3.1.2 Dialysis Reimbursement model
3.1.3 New Product Development
3.1.4 Private Equity (PE) Activity in Dialysis Market
3.2 Growth Drivers
3.2.1 Growing Number of Diabetic Patients Worldwide
3.2.2 Global Dialysis Patient Population
3.2.3 Meliorating Global Economy
3.2.4 Increasing Cases of CKD and ESRD
3.2.5 Increasing Expenditure on Healthcare
List of Tables & Graphs
List of Graphs
GFR across the Stages of CKD
Global Share of ESRD Treatment Procedures (2009-2012)
Global Dialysis Market (2006-2012)
Global Dialysis Market Share by Segments (2012)
Global Dialysis Market Revenue by Segments (2012)
Global Dialysis Product Market (2007-2012)
Global Dialysis Services Market (2007-2012)
Worldwide Breakdown of Center Dialysis & Home Dialysis (2012)
Worldwide Ownership of Dialysis Centers (2012)
Worldwide Regional Dialysis Clinic Operators in 2012
US Dialysis Patients by Payor (2012)
Global Diabetes Population (2006-2012)
Global Diabetes Patients Population by Region (2012)
Dialysis Patient Population Worldwide (2005-2015E)
Dialysis Patient Population Share by Region (2012)
Global GDP (2005-2012)
Global GNI per capita (2007-2012)
Patients with End Stage Renal Disease (2005-2012)
Global Healthcare Expenditure (2007-2011)
Top 5 Dialysis Services Providers Worldwide (2012)
Global Dialysis Products Market Share (2012)
Hemodialysis Products Market Share (2012)
Peritoneal Dialysis Products Market Share (2012)
China’s Dialysis Market by Company (2012)
Hemodialysis Market Share of Domestic and Foreign Manufacturers (2012)
DaVita’s Revenue Share by Business Segments (2012)
DaVita’s Revenue and Net Income Analysis (2009-2012)
Baxter’s Revenue by Business Segments (2012)
View Report Details

8. Table of Contents
3.3 Challenges
3.3.1 Risks and After-Effects of Dialysis
3.3.2 Rising Price Pressure in Healthcare Sector
3.3.3 Stringent Regulation
3.3.4 High Treatment Costs
4. Competitive Landscape
4.1 Global Dialysis Market Competition
-Market Share
-Market Positioning
4.2 Dialysis Product Contention
-Hemodialysis Market Share
-Peritoneal Market Share
4.3 Regional Dialysis Market Contention
4.3.1 China’s Dialysis Market
5. Company Profiles
5.1 DaVita Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
-Focus on Company’s Core Values
-Success through Acquisitions/Partnerships
5.2 Baxter International Inc.
5.2.1 Business Overview
5.2.2 Financial Overview
Baxter’s Revenues and Net Income (2009-2012)
Fresenius Medical Care’ Revenue Share by Business Segments (2012)
Fresenius Medical Care’ Revenue and Net Income Analysis (2009-2012)
Global Dialysis Market Forecast (2011-2015F)
List of Tables
Stages of CKD
Renoprotective Strategies for Slowing Progression of CKD
Symptoms & Treatment of Renal Failure
Advantages and Disadvantages of Dialysis Methods
Distribution of Hemodialysis Device Manufacturers by Region in China
(2012)
Regional Breakdown of Center Dialysis and Home Dialysis
Change in Share Prices of Dialysis providers' (1/7/2013-2/7/2013)
Dialysis Patients Regional Development (2012)
Risk Factors for CKD
Global Market Position in Major Product Groups (2012)
Number of Patients Treated by Region (2012)
Dependent & Independent Variables (2007–2012)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output)
View Report Details

9. Table of Contents
5.2.3 Business Strategies
-Product Portfolio Expansion through R&D
-Strategic Acquisitions & Collaborations
5.3 Fresenius Medical Care
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
-Sustainable Growth Strategy
-Focus on Research & Development
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
View Report Details

10. Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T. +91-120-4130959
C: +91-9811715635
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
Vikas Gupta
BD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “Global Dialysis Market”. To know more
about this report or for any customized research requirement, please contact the following:
View Report Details